Lexicon Pharma (LXRX) Tops Q4 EPS by 3c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.42 +3.42%
Financial Fact:
Other income (expense), net: 564K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Other income (expense), net: 564K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $5.5 million versus the consensus estimate of $3.92 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- AXIL Brands (AXIL) Tops Q4 EPS by 4c
- Klarna shares tumble on weak full-year revenue guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
